| 1 |
Razzokov J, Fazliev S, Makhkamov M, Marimuthu P, Baev A, Kurganov E. Effect of Electric Field on α-Synuclein Fibrils: Revealed by Molecular Dynamics Simulations. IJMS 2023;24:6312. [DOI: 10.3390/ijms24076312] [Reference Citation Analysis]
|
| 2 |
Dutta S, Hornung S, Taha HB, Biggs K, Siddique I, Chamoun LM, Shahpasand-Kroner H, Lantz C, Herrera-Vaquero M, Stefanova N, Loo JA, Bitan G. Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser(129) in Biological Samples. ACS Chem Neurosci 2023. [PMID: 36920792 DOI: 10.1021/acschemneuro.2c00676] [Reference Citation Analysis]
|
| 3 |
Negi D, Granak S, Shorter S, O'Leary VB, Rektor I, Ovsepian SV. Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases. Neurotherapeutics 2023. [PMID: 36884195 DOI: 10.1007/s13311-023-01355-7] [Reference Citation Analysis]
|
| 4 |
Amagai R, Yoshioka S, Otomo R, Nagano H, Hashimoto N, Sakakibara R, Tanaka T, Okado-Matsumoto A. Post-translational modification of lysine residues in erythrocyte α-synuclein. J Biochem 2023;173:177-84. [PMID: 36469357 DOI: 10.1093/jb/mvac100] [Reference Citation Analysis]
|
| 5 |
Schaffrath A, Schleyken S, Seger A, Jergas H, Özdüzenciler P, Pils M, Blömeke L, Cousin A, Willbold J, Bujnicki T, Bannach O, Fink GR, Willbold D, Sommerauer M, Barbe MT, Tamgüney G. Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool. NPJ Parkinsons Dis 2023;9:14. [PMID: 36732520 DOI: 10.1038/s41531-023-00458-4] [Reference Citation Analysis]
|
| 6 |
Bearoff F, Dhavale D, Kotzbauer P, Kortagere S. Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells. Mol Immunol 2023;154:1-10. [PMID: 36571978 DOI: 10.1016/j.molimm.2022.12.006] [Reference Citation Analysis]
|
| 7 |
Deyell JS, Sriparna M, Ying M, Mao X. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies. Int J Mol Sci 2023;24. [PMID: 36768798 DOI: 10.3390/ijms24032477] [Reference Citation Analysis]
|
| 8 |
Sancandi M, De Caro C, Cypaite N, Marascio N, Avagliano C, De Marco C, Russo E, Constanti A, Mercer A. Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model. Front Aging Neurosci 2022;14:986127. [PMID: 36742204 DOI: 10.3389/fnagi.2022.986127] [Reference Citation Analysis]
|
| 9 |
Bagree G, De Silva O, Liyanage PD, Ramarathinam SH, Sharma SK, Bansal V, Ramanathan R. α-synuclein as a potential biomarker for developing diagnostic tools against neurodegenerative disorders. TrAC Trends in Analytical Chemistry 2023. [DOI: 10.1016/j.trac.2023.116922] [Reference Citation Analysis]
|
| 10 |
Neupane S, De Cecco E, Aguzzi A. The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates. J Mol Biol 2022;:167930. [PMID: 36566800 DOI: 10.1016/j.jmb.2022.167930] [Reference Citation Analysis]
|
| 11 |
Kuzkina A, Rößle J, Seger A, Panzer C, Kohl A, Maltese V, Musacchio T, Blaschke S, Tamgüney G, Kaulitz S, Rak K, Scherzad A, Zimmermann P, Klussmann J, Hackenberg S, Volkmann J, Sommer C, Sommerauer M, Doppler K. Combining skin and olfactory α-synuclein RT-QuIC - towards biomarker-driven phenotyping in synucleinopathies.. [DOI: 10.21203/rs.3.rs-2155301/v1] [Reference Citation Analysis]
|
| 12 |
Piccoli T, Blandino V, Maniscalco L, Matranga D, Graziano F, Guajana F, Agnello L, Lo Sasso B, Gambino CM, Giglio RV, La Bella V, Ciaccio M, Colletti T. Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders. Int J Mol Sci 2022;23. [PMID: 36142742 DOI: 10.3390/ijms231810831] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
